Groundbreaking Data from Clinical Trial Further Validates aXivite's Impact on Aerobic Capacity and Performance in Athletes
aXichem AB (publ), (aXichem), a developer of natural analogue industrial compounds, today announces, building upon the previous breakthrough study, a new clinical trial published in Frontiers, with the title “Effects of phenylcapsaicin on aerobic capacity and physiological parameters in active young males: a randomized, triple-blinded, placebo-controlled, crossover trial”